Pulmonary and Nonpulmonary Sepsis Differentially Modulate Lung Immunity toward Secondary Bacterial Pneumonia: A Critical Role for Alveolar Macrophages
Jean‐François Llitjos(Université Paris Cité), Frédéric Pène(Centre National de la Recherche Scientifique), Edwige Péju(Centre National de la Recherche Scientifique), Bruno Lucas(Délégation Paris 5), Clémence Martin(Délégation Paris 5), Zakaria Ait Hamou(Université Paris Cité), Aurélie Durand(Centre National de la Recherche Scientifique), Pierre‐Régis Burgel(Hôpital Cochin), Jean‐Paul Mira(Hôpital Cochin), Maha Zohra Ladjemi(Centre National de la Recherche Scientifique), Christophe Rousseau(Centre National de la Recherche Scientifique), Jean‐Daniel Chiche(Université Paris Cité), Cédric Auffray(Délégation Paris 5)
Cited by 9
Related Papers
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
|Intensive Care Medicine|2017|6.8k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
|Critical Care Medicine|2017|3.8k
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
|Science|2020|3.2k
Gain-of-function human <i>STAT1</i> mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis
|The Journal of Experimental Medicine|2011|797
The REMAP-CAP (Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia) Study. Rationale and Design
|Annals of the American Thoracic Society|2020|444